Completed NA INTERVENTIONAL 2-arm NCT02096302

The Effects of an Infant Formula Containing Probiotic CECT7210 on Gastrointestinal Health (GO-INF)

Evaluar el Efecto de Una fórmula Infantil Enriquecida Con el probiótico CECT7210 Sobre la Incidencia de Infecciones Gastrointestinales

Sponsor: Harrison Clinical Research

Conditions Gastrointestinal Diseases

Interventions Infant Formula with a novel probiotic CECT7210 Standard formula

Updated 6 times since 2017 Last updated: Jul 17, 2019 Started: Jan 31, 2011 Primary completion: Nov 30, 2012 Completion: Jun 30, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Gastrointestinal Diseases, this trial is completed. The trial is conducted by Harrison Clinical Research and has accumulated 6 data snapshots since 2011. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Aug 2019 — Jan 2021 [monthly]

Completed NA

Phase: PHASE4 → NA
Jun 2018 — Aug 2019 [monthly]

Completed PHASE4

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Jan 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Harrison Clinical Research
Laboratorios Ordesa

Data source: Laboratorios Ordesa

For direct contact, visit the study record on ClinicalTrials.gov .

The Effects of an Infant Formula Containing Probiotic CECT7210 on Gastrointestinal Health (GO-INF)

Status Flow

Change History

Eligibility Summary

Contact Information

Study Locations

Related Trials